ResearcherShanghai Jiao Tong UniversityNo recent work listed

Yu Jiang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9455-0844; OpenAlex author ID A5101880516. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2021: 1 paper

Papers 1

Preoperative Score to Stratify Recurrence Risk After Curative Resection of Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Cohort Study Co-author DOI 10.21203/rs.3.rs-697919/v1 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Siyi Zou · 1 shared paper, 2021 · strength 0.15
- Paper Preoperative Score to Stratify Recurrence Risk After Curative Resection of Resectable Pancreatic Ductal Adenocarcinoma:… DOI 10.21203/rs.3.rs-697919/v1 ↗
Weishen Wang · 1 shared paper, 2021 · strength 0.15
- Paper Preoperative Score to Stratify Recurrence Risk After Curative Resection of Resectable Pancreatic Ductal Adenocarcinoma:… DOI 10.21203/rs.3.rs-697919/v1 ↗
Haoda Chen · 1 shared paper, 2021 · strength 0.15
- Paper Preoperative Score to Stratify Recurrence Risk After Curative Resection of Resectable Pancreatic Ductal Adenocarcinoma:… DOI 10.21203/rs.3.rs-697919/v1 ↗
Xiaxing Deng · 1 shared paper, 2021 · strength 0.15
- Paper Preoperative Score to Stratify Recurrence Risk After Curative Resection of Resectable Pancreatic Ductal Adenocarcinoma:… DOI 10.21203/rs.3.rs-697919/v1 ↗
Qian Zhan · 1 shared paper, 2021 · strength 0.15
- Paper Preoperative Score to Stratify Recurrence Risk After Curative Resection of Resectable Pancreatic Ductal Adenocarcinoma:… DOI 10.21203/rs.3.rs-697919/v1 ↗
Baiyong Shen · 1 shared paper, 2021 · strength 0.15
- Paper Preoperative Score to Stratify Recurrence Risk After Curative Resection of Resectable Pancreatic Ductal Adenocarcinoma:… DOI 10.21203/rs.3.rs-697919/v1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.